Compass Therapeutics, a biotechnology company committed to the ambitious goal of comprehensively drugging the human immune system, today announced that it has been named by FierceBiotech as one of 2018’s Fierce 15 biotechnology companies, designating [...]
Vets First Choice has received city approval to commence construction of a new headquarters in Portland, Maine to support its rapid growth and expansion. The new approximately 170,000 square foot facility will support more than [...]
Evox Therapeutics Ltd (‘Evox’ or the ‘Company’), a leading exosome therapeutics company, today announces that it has raised £35.5 million ($45.4 million) of new capital in a Series B financing round. Redmile Group led the [...]
Compass Therapeutics, a biotechnology company committed to the ambitious goal of comprehensively drugging the human immune system, today announced the closing of the final $49 million of its $132 million Series A financing. This financing [...]
For over a decade and a half, the Built Environment Investment Team at Borealis Ventures has been funding and mentoring firms ready to build a better world. As the portfolio and market demand continued to grow, the decision to create a new dedicated venture strategy was a natural one. In 2018, we decided to leverage all of the expertise from the Borealis Ventures Built Environment Investment Team and give it even greater focus by forming Building Ventures, entirely committed to funding disruptive ideas in the built environment for a better built world.
We’re always interested in engaging with inventors, creators, and entrepreneurs to help develop ideas and realize visions.